###### Strengths and limitations of this study

-   A previous study revealed that prewarming the supraglottic device i-gel to 42°C facilitated the insertion efficacy under muscle relaxation in anaesthetised, paralysed patients. However, the utility of prewarming of i-gel for patients in non-paralysed, sedated patients has not been validated as yet.

-   Prewarming of the i-gel did not facilitate insertion efficacy such as insertion success rate or sealing pressure in non-paralysed, sedated patients.

-   Our result suggests that we can keep the i-gel at room temperature for emergent airway management in non-paralysed patients.

-   Our randomised prospective study is performed only in one hospital, large-scale study may be needed in the future.

Introduction {#s1}
============

The supraglottic airway device, i-gel (i-gel: Intersurgical, Wokingham, UK), is a single-use supraglottic device (SGD) with a gel-like cuff and reported to be useful for airway management under general anaesthesia or during resuscitation.[@R1] [@R2]

The i-gel is composed of a thermoplastic elastomer which is suggested to fit the laryngeal structure by body temperature exposure.[@R3] However, a previous study in which i-gel was prewarmed to 37°C did not demonstrate any significant difference in sealing pressure.[@R4] We considered that i-gel prewarmed to 37°C may be cooled during the insertion process and that insertion and higher prewarming temperature could help the cuff exert a higher sealing pressure. We previously reported significant differences in sealing pressure when the i-gel was prewarmed to 42°C under muscle relaxation.[@R5]

As i-gel is used not only under muscle relaxant contexts but also without muscle relaxation in non-paralysed, sedated or cardiopulmonary suppressed patients, we hypothesised that evaluating the prewarming effect in non-paralysed patients preserving spontaneous ventilation would be informative.

Accordingly, the present study was performed to investigate this hypothesis by comparing airway-sealing pressure between i-gel devices prewarmed to 42°C and those kept at room temperature (approximately 23°C) in non-paralysed, sedated patients.

Methods {#s2}
=======

From November 2013 to February 2014, 74 patients aged 20--85 years who were to undergo general anaesthesia (maintaining spontaneous ventilation) in the supine position were assigned at random by using the envelope method to one of the two groups: i-gel prewarmed to 42°C (W group; 37 patients) and i-gel kept at room temperature (C group; 37 patients). Exclusion criteria included difficult airway such as mouth opening restriction and any contraindication for the use of SGDs (eg, morbid obesity (body mass index, \>35), gastro-oesophageal reflux and previous upper abdominal surgery) or a recent history (within 7 days) of upper respiratory tract infection.[@R4]

Routine monitoring of blood pressure, heart rate, ECG, percutaneous oxygen saturation and end-tidal carbon dioxide tension was performed. Without any premedication, propofol 1--2 mg/kg and fentanyl 1.0--2.0 μg/g were administered to patients. Doses of sedatives and analgesics were limited so as to maintain spontaneous ventilation to a certain extent. In case of loss of respiratory arrest, the anaesthesiologist performed mask ventilation until the recovery of spontaneous ventilation. The i-gel was warmed to 42°C in a heating cabinet with an automatic temperature control for 30 min before use in the W group. The time from i-gel delivery from the heating cabinet to insertion into the mouth is approximately 30--60 s. The approximate temperature of the i-gel was 37--39°C at the time of insertion, which was measured in the preliminary study. On the basis of this preliminary study, we decided the prewarming to 42°C.[@R5] For the C group, i-gel was stored at room temperature (approximately 23°C). A thermometer was used to measure the temperature of the heating cabinet directly. The decision of whether to use a size 3 or 4 i-gel was based on the patient\'s body weight, as per the manufacturer\'s instructions. The anaesthesiologist made size determinations for patients weighing 50--60 kg (ie, between sizes 3 and 4). Sealing pressure was measured after insertion of i-gel with the indicator attached to the anaesthesia machine. Successful insertion was confirmed by bilateral chest wall movement, auscultation and normal capnograms; a sealing pressure of \>15 cm H~2~O was considered a successful insertion. In case of failed ventilation, an insertion trial was immediately performed, and the number of insertion attempts was recorded. However, if the third attempt failed, the trial was recorded as a failure, and airway management with the LMA-ProSeal was performed. Sealing pressure was compared in successful cases between the W and C groups.

Following successful ventilation, anaesthesia was maintained with inhalation of sevoflurane and 33--40% nitrous oxide in oxygen in order to maintain spontaneous ventilation. Patients were extubated postoperatively, and hoarseness and pharyngeal pain after arousal were assessed by non-blinded anaesthesiologists.

Statistical analysis was performed with JMP 11 (SAS Institute Inc, Cary, North Carolina, USA). The χ^2^ test and Mann-Whitney U test were used for data pertaining to patient characteristics. The χ^2^ test was used for the number of insertion attempts and hoarseness and pharyngeal pain incidents. The Mann-Whitney U test was used to compare sealing pressure. Data are presented as mean±SD with 95% CIs. p Value \<0.05 was considered statistically significant.

With respect to sample size, the incidence of successful i-gel insertions (sealing pressure \>15 cm H~2~O on first insertion) in a non-warming preliminary trial in the previous study with muscle relaxation was approximately 50%. As such, we hypothesised that prewarming i-gel would increase the successful insertion rate to 80%.[@R5] To detect this difference with 80% power at a 5% significance level, 36 patients would be necessary in each group. Therefore, we planned to recruit 37 patients for each group to adjust for missing data.

Results {#s3}
=======

Patient characteristics are shown in [table 1](#BMJOPEN2014006653TB1){ref-type="table"}. None of the following parameters differed significantly between the W and C groups: age, sex, body weight, height, body mass index, duration of surgery, duration of anaesthesia, Mallampati score and i-gel size used.

###### 

Patient characteristics

  -------------------------------------------------------------------
                                  C group\     W group\     p Value
                                  N=37         N=37         
  ------------------------------- ------------ ------------ ---------
  Age                             55.0±16.7    56.5±16.0    0.34

  Gender (male/female)            22/15        18/19        0.48

  Body weight (kg)                60.5±10.9    59.7±14.9    0.39

  Height (cm)                     162.9±8.7    161.7±9.4    0.27

  BMI (kg/m^2^)                   22.7±3.0     22.7±4.2     0.39

  Duration of surgery (min)       132.8±65.9   136.9±60.2   0.42

  Duration of anaesthesia (min)   84.5±55.8    87.2±52.9    0.39

  ASA 1/2/3/4                     27/4/6/0     22/10/5/0    0.20

  Mallampati score 1/2/3/4        32/2/3/0     32/5/0/0     0.11

  i-gel size 3/4                  14/23        19/18        0.34
  -------------------------------------------------------------------

Data are presented as mean±SD or number of patients. No differences were observed between the two groups.

C group: i-gel kept at room temperature; W group: i-gel prewarmed to 42°C.

ASA, American Society of Anesthesiologists; BMI, body mass index.

Number of attempts to successful insertion and sealing pressure {#s3a}
---------------------------------------------------------------

The number of insertion attempts was one for 35 cases and two for 2 cases in the W group, and one for 35 cases and two for 1 case in the C group. There was also one failure case in the C group. The number of successful ventilations in the first trial did not significantly differ between the W and C groups (p=0.51). After successful insertion, the sealing pressure was slightly, but not significantly, higher in the W group than in the C group (W group 22.6±6.1 cm H~2~O; C group 20.7±6.1 cm H~2~O; p=0.15; [table 2](#BMJOPEN2014006653TB2){ref-type="table"}).

###### 

Comparison of factors related to airway management between the prewarmed and control groups

  ---------------------------------------------------------------------------------------------------
                                                                      C group\   W group\   p Value
                                                                      N=37       N=37       
  ------------------------------------------------------------------- ---------- ---------- ---------
  Number of attempts required for successful ventilation 1/2/3/fail   35/1/0/1   35/2/0/0   0.51

  Sealing pressure on successful ventilation (cm H~2~O)               20.7±6.1   22.6±6.1   0.15

  Number of patients with hoarseness                                  0          0          1.00

  Number of patients with pharyngeal pain                             1          1          1.00
  ---------------------------------------------------------------------------------------------------

Data are presented as mean±SD or number of patients.

C group: i-gel kept at room temperature; W group: i-gel prewarmed to 42°C.

Incidence of hoarseness and pharyngeal pain after general anaesthesia {#s3b}
---------------------------------------------------------------------

Hoarseness was not seen in either group. However, one patient each in both groups experienced pharyngeal pain, although the incidence of these events did not significantly differ between the two groups ([table 2](#BMJOPEN2014006653TB2){ref-type="table"}).

Discussion {#s4}
==========

The pharyngeal sealing pressure, also known as leak pressure, is a measure of how well an SGD seals the laryngeal structure. A higher sealing pressure is an indicator of how well a device might perform during controlled ventilation. Moreover, the i-gel has already been shown to exhibit better airway-sealing pressure than conventional SGDs.[@R1]

Previous reports have suggested that the thermoplastic nature of the material from which the i-gel cuff is manufactured may conform to the laryngeal anatomy as it approaches body temperature.[@R1] [@R2] The sealing pressure of i-gel is suggested to improve over time, which might be due to the thermoplastic property of the cuff which may form a more efficient seal around the larynx after warming to body temperature.[@R6] [@R7] These reports noted that the sealing pressure appeared to improve over time, suggesting that the i-gel formed a more efficient seal around the larynx after warming to body temperature. In a previous study which used muscle relaxants, the sealing pressure was higher and leak volume smaller after prewarming the i-gel to 42°C.[@R5]

The hypothesis tested in this study was that prewarming of i-gel to 42°C would enable the cuff to fit the pharyngeal structure more quickly than if it was stored at room temperature in both non-paralysed, sedated patients. However, we found that the warmed i-gel did not significantly increase successful airway management with a high sealing pressure, in the absence of muscle relaxants. One possible reason is the administration of muscle relaxants which may be attributed to changes in the pharyngeal space.[@R8] Since muscle relaxants reduce the pharyngeal space and occasionally collapse the upper airway, the fit of the i-gel might be partially augmented by muscle relaxation.[@R8] [@R9] It may be worth evaluating the effects of muscle relaxants on the insertion success rate and sealing pressure of i-gel in a future study.

SGDs are suited for difficult airway management, especially in a 'cannot intubate, cannot ventilate' situation.[@R10] Furthermore, SGDs are used in emergent airway management during resuscitation or emergent respiratory suppression.[@R11] For example, the sedation guidelines of the American Society of Anesthesiologists indicate that SGDs are useful for airway rescue in oversedated patients.[@R12] Furthermore, airway management is considered as an essential element of both in-hospital and out-of-hospital cadiopulmonary resuscitation. Tracheal intubation is the most widely used method for airway management, but is considered difficult for occasional users.[@R13] The AHA-ACLS guidelines emphasise continuous chest compression, and avoiding interruptions as much as possible, even for airway management.[@R14] However, the guidelines do not recommend tracheal intubation for all rescuers, but rather suggest SGDs as alternatives.[@R15] In emergent situations, such as oversedation or resuscitation, patients are not paralysed by muscle relaxants. Our data suggest that prewarming of i-gel is not needed for emergent airway management for non-paralysed patients.

This study has several limitations. First, we performed the power analysis based on a previous study with a muscle relaxant. Power analysis based on without muscle relaxation may provide more practical number. The study may be underpowered as the power analysis was based on a previous study using a muscle relaxant, and the fit of the i-gel might be partially augmented by muscle relaxation. Also, the number of additional cases for missing cases may be relatively small. Second, sealing pressure was measured only once immediately after insertion and sealing may have improved over time. Subsequent sealing pressure monitoring may clarify the effect of i-gel prewarming. Third, as this study was conducted at a single institute, a multicentre study or a meta-analysis would clarify the utility of prewarming of i-gel. Fourth, we did not fix the dose of anaesthetic drugs which may yield a non-blinded bias.

In conclusion, we found that the prewarmed i-gel did not provide a higher success rate for insertion or higher sealing pressure in non-paralysed, sedated patients who were not treated with muscle relaxants, as compared with i-gel kept at room temperature.

Supplementary Material
======================

###### Author\'s manuscript

###### Reviewer comments

**Contributors:** NK designed the study, analysed the data and wrote the manuscript. IN designed and conducted the study. ST conducted the study and analysed the data. TM designed the study and wrote the manuscript.

**Funding:** Financial support for the study was provided by the authors' institutions.

**Competing interests:** None.

**Patient consent:** Obtained.

**Ethics approval:** Hokusetsu General Hospital Ethical Committee.

**Provenance and peer review:** Not commissioned; externally peer reviewed.

**Data sharing statement:** No additional data are available.
